©The Author(s) 2019.
World J Hepatol. Dec 27, 2019; 11(12): 752-760
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Published online Dec 27, 2019. doi: 10.4254/wjh.v11.i12.752
Table 3 Predisposing factors, n (%)
| Predisposing factors | GCH on native liver | GCH on allograft |
| AIH | 13 (32) | 3 (30) |
| Drug induced | 6 (15) | 0 |
| No factor identified | 12 (30) | 3 (30) |
| UC | 2 (5) | 3 (30) |
| PSC | 3 (7) | 1 (10) |
| HCV | 2 (5) | 1 (10) |
| CMV | 1 (2) | 1 (10) |
| SLE | 2 (5) | 0 |
| Lymphoma | 2 (5) | 0 |
| HAV | 1 (2) | 0 |
| HBV | 1 (2) | 0 |
| EBV | 1 (2) | 0 |
| Sjogren | 1 (2) | 0 |
| Autoimmune hemolytic anemia | 1 (2) | 0 |
| CLL | 1 (2) | 0 |
| Peripheral eosinophilia | 1 (2) | 0 |
| SCC | 1 (2) | 0 |
| Celiac disease | 1 (2) | 0 |
- Citation: Matta B, Cabello R, Rabinovitz M, Minervini M, Malik S. Post-infantile giant cell hepatitis: A single center’s experience over 25 years. World J Hepatol 2019; 11(12): 752-760
- URL: https://www.wjgnet.com/1948-5182/full/v11/i12/752.htm
- DOI: https://dx.doi.org/10.4254/wjh.v11.i12.752